SEC 13F Intelligence

Nantahala Capital Management, LLC / ZVRA

Nantahala Capital Management, LLC’s Zevra Therapeutics Inc Position

Does Nantahala Capital Management, LLC own Zevra Therapeutics Inc (ZVRA)? Yes — 2.52M shares worth $24M (+0.87% of its 13F portfolio) as of Q1 2026, up from 1.77M shares the prior filed quarter.

Position Value
$24M
Q1 2026
Shares
2.52M
% of Portfolio
+0.87%
Quarters Held
11
currently held

Position History ZVRA

Reported value by quarter
Q3 ’23: $11MQ3 ’23Q4 ’23: $32MQ1 ’24: $14MQ1 ’24Q2 ’24: $24MQ3 ’24: $20MQ3 ’24Q4 ’24: $20MQ1 ’25: $11MQ1 ’25Q2 ’25: $13MQ3 ’25: $19MQ3 ’25Q4 ’25: $16MQ1 ’26: $24MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.52M$24M+0.87%
Q4 20251.77M$16M+0.52%
Q3 20251.97M$19M+0.65%
Q2 20251.47M$13M+0.51%
Q1 20251.47M$11M+0.44%
Q4 20242.34M$20M+0.84%
Q3 20242.92M$20M+1.03%
Q2 20244.84M$24M+0.70%
Q1 20242.45M$14M+0.81%
Q4 20234.91M$32M+0.96%
Q3 20232.31M$11M+0.95%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nantahala Capital Management, LLC’s full portfolio or all institutional holders of ZVRA.